[CYCC] YoY Quarter Result on 30-Sep-2011 [#Q3]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
14-Nov-2011
Financial Year
2011
Quarter
30-Sep-2011 [#Q3]
Profit Trend
QoQ- 3.01%
YoY- 9.51%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 CAGR
Revenue 735 309 38 164 159 230 269 18.22%
PBT -5,661 -5,746 -3,572 -3,571 -3,950 -3,329 -18,058 -17.57%
Tax -750 -730 -419 -126 -143 -205 -411 10.53%
NP -4,907 -5,004 -1,890 -3,445 -3,807 -3,124 -17,647 -19.20%
Tax Rate - - - - - - - -
Total Cost 5,642 5,313 1,928 3,609 3,966 3,354 17,916 -17.50%
Ratio Analysis
30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 CAGR
NP Margin -667.62 -1,619.42 -4,973.68 -2,100.61 -2,394.34 -1,358.26 -6,560.22 -31.65%
Per Share
30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 CAGR
EPS -51.93 -67.51 -53.81 -107.75 -172.72 -226.51 -1,450.99 -42.57%
EPS Diluted -51.93 -67.51 -53.81 -107.75 -172.72 -226.51 -1,450.99 -42.57%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.